Augusto Guerra
Visiting Associate Professor of Epidemiology
Research Interests
Professor Guerra's teaching and research interests span pharmacoepidemiology, pharmacoeconomics, health technology assessment (HTA), pharmaceutical policy, and health policy configuration, with particular emphasis on the real-world effectiveness, safety, and value of high-cost medicines and advanced therapies. His work integrates epidemiologic methods, causal inference, and real-world evidence (RWE) with genomic and pharmacogenomic data to support evidence-based decision-making in healthcare systems.
Professor Guerra is particularly interested in combining genomics, AI-enabled analytics, and population-based data to evaluate treatment effectiveness and survival outcomes, heterogeneity of response, and value-based pricing of innovative medicines, especially in oncology and rare diseases.
Email
In addition to to his position at MBZUAI, Professor Guerra is a Professor at the Universidade Federal de Minas Gerais (UFMG), Brazil. At UFMG, he coordinates the Collaborating Center for Health Technology Assessment and Excellence in Health (CCATES/UFMG) and the Pharmacogenomics Research Laboratory (FarGenix/UFMG), leading interdisciplinary research at the interface of epidemiology, genomics, health policy, and real-world data. His work supports regulatory, reimbursement, and pricing decisions related to high-cost medicines within public health systems. Professor Guerra J˙nior collaborates with researchers from Uppsala University (Sweden), University of Strathclyde (Scotland), University of Bordeaux (France), as well as international organizations including the World Bank and the Pan American Health Organization (PAHO/WHO).
- Ph.D. in Public Health (Epidemiology) from Federal University of Minas Gerais (UFMG).
- Master of Science in Pharmaceutical Sciences from University of BrasÌlia (UnB).
- Bachelor of Science in Pharmacy from Federal University of Minas Gerais (UFMG).
- National Commission for the Incorporation of Technologies in the SUS (Brazilian Public Health System), CONITEC Five Years, Tribute to Collaborators, 2016.
- Honorable mention for doctoral thesis, Science and Technology Award for the SUS, 2010.
- Diploma of Pharmaceutical Merit, Regional Pharmacy Council of Minas Gerais, 2009.
- Sergio Arouca Award for Participatory Management, Ministry of Health, 2008.
- Gargano, L. P., Borin, M. C., Prata, W. M., Alvares-Teodoro, J., Acurcio, F. d. A., Iunes, R. F., & Guerra, A. A., Jr.: "The Pharmaceutical Innovativeness Index: Supporting Value-Based Economic Regulation of Innovative Medicines." Journal of Market Access & Health Policy, 2025.
- Guerra Jr, AA; Alvares Teodoro, J; Martins, B; Silva, MN; Moreira, AJ; Borin, M; Rodrigues, B; Nassif, L; Curcio, FA; Rossi, I; Lula, M; VilaÁa, K.: "Brazil Ministry of Health. Secretariat of Science, Technology, Innovation and Health Complex. National Commission for Technology Incorporation in the Unified Health System (Conitec) – Nusinersen for the treatment of patients with Spinal Muscular Atrophy (SMA) type II and type III with onset of symptoms after six months of age. Recommendation report, Brasilia, Ministry of Health, 2025.
- Vieira J.C.M., Reis E.A., Prata W.M., de Oliveira H.N., Ruas C.M., Guerra Junior A.A.: "Effectiveness of clozapine compared to non-clozapine antipsychotics in older adults with schizophrenia in Brazil: a 16-year follow-up." American Journal of Geriatric Psychiatry, 2025.
- Alves T.M., Prata W.M., Borin M.C., et al., Guerra Junior A.A.: "Seven-year overall survival of trastuzumab versus alternative systemic therapies in a Brazilian breast cancer cohort." Scientific Reports, 2025.
- Gargano L.P., Alvares-Teodoro J., de Assis Acurcio F., Guerra Junior A.A.: "Pharmaceutical Innovativeness Index: methodological approach for assessing the value of medicines ñ a case study of oncology drugs." Expert Review of Pharmacoeconomics & Outcomes Research, 2024.
- Guerra Jr, AA; Alvares Teodoro, J; Martins, B; Silva, MN; Moreira, AJ; Borin, M; Rodrigues, B; Nassif, L; Curcio, FA; Rossi, I; Lula, M; VilaÁa, K., BRAZIL. Ministry of Health. Secretariat of Science, Technology, Innovation and Health Complex. National Commission for Technology Incorporation in the Unified Health System (Conitec): "Recommendation Report: Clinical Protocol and Therapeutic Guidelines for Multiple Sclerosis (Public Consultation No. 08/2023)." BrasÌlia: Ministry of Health, 2023.
- Silva M.N., Lula M.D., Felício L.R., Santos B., Nassif L.S., Borin M.C., Alvares-Teodoro J., Acurcio F.A., Guerra A.A." "Genetic markers involved in neuroinflammation in Down syndrome: a systematic review." Dement Neuropsychol, 2025.
- Melo A.P.S., Dippenaar I.N., Johnson S.C., et al., Guerra Junior A.A.: "All-cause and cause-specific mortality among people with severe mental illness in Brazil's public health system, 2000-2015." The Lancet Psychiatry, 2022.
- de Figueiredo L.O., Guerra Junior A.A., de Assis Acurcio F., et al: "A demographic and clinical panorama of a sixteen-year cohort of soft tissue sarcoma patients in Brazil." Scientific Reports, 2021.